Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System

DEVICE2 trials

Sponsors

Medtronic Vascular

Conditions

ArteriosclerosisCardiovascular DiseasesCoronary Artery DiseaseIschemic Heart DiseaseStenotic Coronary Lesion

Phase 3

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

CompletedNCT02452736

Medtronic VascularArteriosclerosis, Cardiovascular Diseases, Coronary Artery Disease +1

Start: 2015-05-31End: 2015-12-31Updated: 2016-04-07

Unknown Phase

RESOLUTE ONYX China RCT Study

Active, not recruitingNCT03466151

Medtronic VascularArteriosclerosis, Cardiovascular Diseases, Coronary Artery Disease +2

Start: 2018-04-12End: 2026-07-31Updated: 2026-04-22